Patents by Inventor Wonduck Kim

Wonduck Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL STRAINS HAVING EFFECTS OF PREVENTING OR TREATING CANCERS
    Publication number: 20210322490
    Abstract: The present invention relates to a novel Bifidobacterium bifidum MG731 strain and a composition for preventing or treating cancers, comprising the same. Specifically, the Bifidobacterium bifidum MG731 strain of the present invention has effects of inhibiting the proliferation of cancer cells, decreasing the mobility of cancer cells, inhibiting the neoangiogenesis, and increasing the anticancer immune response as well as reducing the expression of inflammatory factors, thereby having effects of preventing or treating cancers or inflammatory diseases. In addition, when used in combination with an anticancer chemotherapeutic agent or an anticancer immunotherapeutic agent, the Bifidobacterium bifidum MG731 strain of the present invention exhibits a better anticancer effect. In addition, the present invention relates to a novel Lactococcus lactis GEN3033 strain and a composition for preventing or treating cancers, comprising the same.
    Type: Application
    Filed: May 8, 2019
    Publication date: October 21, 2021
    Applicant: Genome And Company
    Inventors: Hansoo Park, Shinyoung Park, Eun Ju Lee, Jae-Sung Yeon, Hye Hee Jeon, Wonduck Kim, Joo-Yeon Chung, Areum Jeong, Youn Kyung Houh, Jinyoung Sohn, Yun Yeon Kim, Sang Gyun Kim, Suro Lee
  • NOVEL STRAINS HAVING EFFECTS OF PREVENTING OR TREATING CANCERS
    Publication number: 20210138003
    Abstract: The present invention relates to a novel Bifidobacterium bifidum MG731 strain and a composition for preventing or treating cancers, comprising the same. Specifically, the Bifidobacterium bifidum MG731 strain of the present invention has effects of inhibiting the proliferation of cancer cells, decreasing the mobility of cancer cells, inhibiting the neoangiogenesis, and increasing the anticancer immune response as well as reducing the expression of inflammatory factors, thereby having effects of preventing or treating cancers or inflammatory diseases. In addition, when used in combination with an anticancer chemotherapeutic agent or an anticancer immunotherapeutic agent, the Bifidobacterium bifidum MG731 strain of the present invention exhibits a better anticancer effect. In addition, the present invention relates to a novel Lactococcus lactis GEN3033 strain and a composition for preventing or treating cancers, comprising the same.
    Type: Application
    Filed: November 12, 2020
    Publication date: May 13, 2021
    Applicant: Genome And Company
    Inventors: Hansoo Park, Shinyoung Park, Eun Ju Lee, Jae-Sung Yeon, Hye Hee Jeon, Wonduck Kim, Joo-Yeon Chung, Areum Jeong, Youn Kyung Houh, Jinyoung Sohn, Yun Yeon Kim, Sang Gyun Kim, Suro Lee